Deutsche Bank Ag\ Elevation Oncology, Inc. Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$0.26 - $0.84 $830 - $2,682	-3,193 Reduced 1.69%	185,578 $48,000
Q4 2024 Jun 30, 2025	BUY	$0.51 - $0.76 $1,628 - $2,426	3,193 Added 1.72%	188,771 $109,000
Q4 2024 Feb 14, 2025	BUY	$0.51 - $0.76 $81,473 - $121,410	159,751 Added 550.49%	188,771 $109,000
Q3 2024 Jun 26, 2025	SELL	$0.56 - $3.02 $87,672 - $472,805	-156,558 Reduced 84.36%	29,020 $17,000
Q2 2024 Jun 12, 2025	SELL	$2.35 - $5.17 $367,911 - $809,404	-156,558 Reduced 84.36%	29,020 $78,000

Q2 2024 Aug 14, 2024	BUY	$2.35 - $5.17 $68,197 - $150,033	29,020 New	29,020 $78,000

2.67M

Ticker ELEV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,300,900
Market Cap $8.39M
Description
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.